GB0411153D0 - Compositions and methods for inhibiting bone resorption - Google Patents

Compositions and methods for inhibiting bone resorption

Info

Publication number
GB0411153D0
GB0411153D0 GBGB0411153.0A GB0411153A GB0411153D0 GB 0411153 D0 GB0411153 D0 GB 0411153D0 GB 0411153 A GB0411153 A GB 0411153A GB 0411153 D0 GB0411153 D0 GB 0411153D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
bone resorption
inhibiting bone
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB0411153.0A
Other versions
GB2414181A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GB0411153A priority Critical patent/GB2414181A/en
Publication of GB0411153D0 publication Critical patent/GB0411153D0/en
Publication of GB2414181A publication Critical patent/GB2414181A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0411153A 2004-05-19 2004-05-19 compositions containing a bisphosphonate and a Vitamin D derivative Pending GB2414181A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0411153A GB2414181A (en) 2004-05-19 2004-05-19 compositions containing a bisphosphonate and a Vitamin D derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0411153A GB2414181A (en) 2004-05-19 2004-05-19 compositions containing a bisphosphonate and a Vitamin D derivative

Publications (2)

Publication Number Publication Date
GB0411153D0 true GB0411153D0 (en) 2004-06-23
GB2414181A GB2414181A (en) 2005-11-23

Family

ID=32607576

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0411153A Pending GB2414181A (en) 2004-05-19 2004-05-19 compositions containing a bisphosphonate and a Vitamin D derivative

Country Status (1)

Country Link
GB (1) GB2414181A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20120393A1 (en) * 2012-03-14 2013-09-15 Tiberio Bruzzese AQUEOUS FORMULATIONS OF BISPHOSPHONATES, VITAMIN D AND BENZYL ALCOHOL SUITABLE FOR INTRAMUSCULAR OR SUBCUTANEOUS USE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
EP1400810A3 (en) * 1999-04-09 2005-03-02 Karo Bio Ab Estrogen receptors and bone disease
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
US20020004218A1 (en) * 2000-03-31 2002-01-10 Rodan Gideon A. Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase
CA2454200A1 (en) * 2001-07-17 2003-01-30 Teva Pharmaceutical Industries Ltd. Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
EP1458400A1 (en) * 2001-12-13 2004-09-22 Merck & Co., Inc. Liquid bisphosphonate formulations for bone disorders
US20050176685A1 (en) * 2002-04-05 2005-08-11 Daifotis Anastasia G. Method for inhibiting bone resorption with an alendronate and vitamin d formulation

Also Published As

Publication number Publication date
GB2414181A (en) 2005-11-23

Similar Documents

Publication Publication Date Title
IL179241A0 (en) Compositions and methods for bone formation and remodeling
AP2089A (en) Compositions and methods for combination antiviraltherapy
EP1633718A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING TGF-s
EP1734904A4 (en) Cement-directing orthopedic implants
AU2003300099A8 (en) Compositions and methods for inhibiting tgf-beta
HK1102712A1 (en) Apparatuses for bone restoration
HK1088907A1 (en) Compositions and methods for increasing bone mineralization
HK1125868A1 (en) Compositions and methods for treating bone
ZA200703908B (en) Compositions for HCV treatment
EP1968483A4 (en) Bioabsorbable surgical composition
HK1121952A1 (en) Methods and compositions for treating conditions
GB0522287D0 (en) Method and compositions
EP1660663A4 (en) Methods and compositions for tissue repair
IL182366A0 (en) Bone implant device
EP1720493A4 (en) Spinal implant
IL220806A0 (en) Method and compositions for enhancing vascular access
IL191237A0 (en) Compositions and methods for treating thrombocytopenia
ZA200808245B (en) Compositions and methods for inducing bone growth and inhibiting bone loss
IL175345A0 (en) Methods and compositions for selectin inhibition
IL175389A0 (en) Methods and compositions for selectin inhibition
GB0524927D0 (en) Compositions and method
GB0406822D0 (en) Surgical fastening
GB0511235D0 (en) Compositions and method
EP1851190A4 (en) Compositions and methods for inhibiting pain
GB0424051D0 (en) Compounds and compositions

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1090539

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1090539

Country of ref document: HK